Drug Search Results
More Filters [+]

JMB-2004

Alternative Names: JMB-2004, JMB 2004, JMB2004
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Jiangsu Jiye Biopharmaceutical Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for JMB-2004

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Shock, Septic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20242338

P1

Unknown

Shock, Septic

None

Recent News Events

Date

Type

Title